Orchid Pharma Limited
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Orchid Pharma Limited's balance sheet done over the years? Its assets were worth $15,538,739,000 last year, which is more than in the previous period. 25% of Orchid Pharma Limited’s total assets is currently financed by debt. Its liabilities reached the amount of $3,844,078,000, which means an decrease by -17% compared compared to last year.
Debt to Assets
| 2012 | 39863613000 | 28.02B | 70.31% |
|---|---|---|---|
| 2013 | 46510391000 | 42.70B | 91.82% |
| 2015 | 40613951000 | 37.32B | 91.89% |
| 2016 | 38620721000 | 38.13B | 98.73% |
| 2018 | 31253694000 | 39.17B | 125.33% |
| 2019 | 30770350000 | 37.81B | 122.88% |
| 2020 | 17216558000 | 6.97B | 40.5% |
| 2021 | 12372521000 | 5.84B | 47.23% |
| 2022 | 11105625000 | 4.63B | 41.71% |
| 2024 | 15538739000 | 3.84B | 24.74% |
ORCHPHARMA.NS Balance Sheet (2012 – 2023)
| 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 36.00M | 43.06M | 156.93M | 898.91M | 923.10M | 351.13M | 3.14B | 3.90B | 234.23M | 1.78B |
Short term investments | 146K | 5.20M | 158.20M | 122K | 2.33B | 2.70B | -6.73M | 0 | 0 | 0 |
Net receivables | 1.95B | 2.66B | 3.58B | 3.32B | 1.32B | 1.21B | 4.15B | 3.61B | 0 | 0 |
Inventory | 2.64B | 1.72B | 1.52B | 1.55B | 1.69B | 1.93B | 2.41B | 2.51B | 5.06B | 6.68B |
Other current assets | 3.27B | 58.87M | 69.85M | 89.86M | 700.26M | 603.17M | 2.79B | 2.74B | 0 | 4.92B |
Total current assets | 7.90B | 4.49B | 5.49B | 5.87B | 6.97B | 6.78B | 12.51B | 12.78B | 11.01B | 13.40B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 6.45B | 6.04B | 6.77B | 10.98B | 19.26B | 20.47B | 23.23B | 16.64B | 27.76B | 20.17B |
Goodwill | 0 | 0 | 0 | 0 | 948.23M | 948.23M | 948.23M | 948.23M | 948.23M | 0 |
Intangible assets | 149.18M | 3.37M | 3.68M | 286.34M | 351.51M | 373.71M | 445.09M | 513.76M | 726.75M | 0 |
Long term investments | 458.39M | 454.98M | 4.17M | 3.38M | -2.32B | -2.69B | 14.85M | 8.11M | 9.48M | 0 |
Other non-current assets | 572.49M | -6.38B | 51.17M | -3.57M | 10.77B | 2.27M | 1.47B | 9.88B | -29.44B | 6.28B |
Total non-current assets | 7.63B | 6.60B | 6.87B | 11.34B | 23.79B | 24.46B | 26.10B | 27.83B | 29.44B | 26.46B |
Total assets | 15.53B | 11.10B | 12.37B | 17.21B | 30.77B | 31.25B | 38.62B | 40.61B | 46.51B | 39.86B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 123.23M | 60.90M | 87.47M | 2.28B | 3.34B | 1.15B | -1.57B | 0 | 0 |
Short term debt | 143.80M | 597.88M | 252.42M | 624.22M | 18.05B | 13.08B | 8.37B | 7.16B | 0 | 6.47B |
Total current liabilities | 2.59B | 2.40B | 1.42B | 1.80B | 23.43B | 20.12B | 13.37B | 11.22B | 32.06B | 15.04B |
| Non-current liabilities: | ||||||||||
Long term debt | 1.20B | 2.08B | 4.27B | 5.01B | 14.24B | 18.93B | 23.77B | 24.93B | 9.01B | 10.74B |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 36.33M | -2.08B | -4.27B | -5.03B | 98.93M | 107.09M | 978.73M | 41.79M | -9.01B | 540.60M |
Total non-current liabilities | 1.24B | 2.22B | 4.42B | 5.16B | 14.37B | 19.04B | 24.75B | 26.09B | 9.01B | 12.98B |
Total liabilities | 3.84B | 4.63B | 5.84B | 6.97B | 37.81B | 39.17B | 38.13B | 37.32B | 42.70B | 28.02B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |